View News Comments
 |
 |
Link Information - Click to View
Rate Story:
Total votes: 0
Biogen plans late-stage Alzheimer's trial, shares rise
Biogen Idec Inc's research chief on Tuesday said the company is planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and significantly improved cognition in a small early-stage study.
Biogen Idec Inc's research chief on Tuesday said the company is planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and significantly improved cognition in a small early-stage study.
Source: Reuters
Posted on: Wednesday, Dec 03, 2014, 8:13am
Views: 1711
Posted on: Wednesday, Dec 03, 2014, 8:13am
Views: 1711
 |
 |
Add Comment?
 |
 |
Friends